Y.B Urban Renewal - Residential Development LTD Logo

Y.B Urban Renewal - Residential Development LTD

CSURE-M | TA

Overview

Corporate Details

ISIN(s):
IL0001110134
LEI:
Country:
Israel
Address:
2 Hahadarim Street, 7712102 Ashdod
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cannassure-M focuses on the development and production of medical cannabis products in Israel.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 19:43
Regulatory News Service
Trading in the company's shares (ISIN IL0001110134) will be renewed on Monday, …
Hebrew (modern) 113.5 KB
2025-05-05 15:53
Regulatory News Service
The securities not included in the Illiquid list as of May 4th 2025 due to mar…
Hebrew (modern) 217.1 KB
2025-05-05 11:32
Regulatory News Service
Suspension of trading due to failure in publication of financial reports s for …
Hebrew (modern) 79.7 KB
2025-04-28 18:40
Regulatory News Service
Securities that have joined the program and the Market Makers that will operate…
Hebrew (modern) 366.8 KB
2025-04-20 18:21
Regulatory News Service
Failure in publishing financial reports-Notification
Hebrew (modern) 128.0 KB
2025-03-06 18:39
Regulatory News Service
Illiquid Candidates securities list as of May 4th 2025
Hebrew (modern) 245.6 KB
2024-07-28 18:05
Regulatory News Service
The company's securities will be transferred from the maintenance list to the m…
Hebrew (modern) 106.5 KB
2024-07-11 17:14
Regulatory News Service
Changes in the company's share symbol correction: YBRD-M
Hebrew (modern) 104.0 KB
2024-07-09 17:01
Regulatory News Service
Changes in the company's name and security, effective as of July 11, 2024
Hebrew (modern) 105.9 KB
2024-06-25 19:48
Regulatory News Service
Changes in Sector Classification of Listed Companies as of Sunday, June 30, 2024
Hebrew (modern) 135.9 KB
2024-03-21 18:45
Regulatory News Service
Will trade on Monday March 25 2024, with unlimited price fluctuation at the ope…
Hebrew (modern) 137.2 KB
2023-07-13 20:43
Regulatory News Service
Transfer to the Maintenance List on July 17, 2023
Hebrew (modern) 149.7 KB
2023-07-03 19:48
Regulatory News Service
Companies that do not comply with the Maintenance Rules and are candidates to b…
Hebrew (modern) 116.3 KB
2023-01-15 17:37
Regulatory News Service
Non-Compliance with the Maintenance Rules Based on Data as of December 31, 2022…
Hebrew (modern) 132.9 KB
2021-01-07 15:45
Regulatory News Service
On Sunday, 10 January 2021, trading will commence in the following Security: CA…
Hebrew (modern) 186.1 KB

Automate Your Workflow. Get a real-time feed of all Y.B Urban Renewal - Residential Development LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y.B Urban Renewal - Residential Development LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y.B Urban Renewal - Residential Development LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HYUNDAI BIOLAND Co.,Ltd. Logo
Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.
South Korea 052260
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea 424870
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan 4570
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom N/A
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV

Talk to a Data Expert

Have a question? We'll get back to you promptly.